946-54990-08568
3 vaccinations
2 coded responses
5 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 980 / WA
- Registered
- 2021-04-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-08
Dose 1 — Pfizer-BioNTech
-
2021-03-08
Dose 2 — Pfizer-BioNTech
-
2021-04-04
Registered in v-safe
-
2021-04-05
Survey response — day 28, dose 2MedDRA: Arthralgia, Eye disorder, Headache, Pain in extremity — Feeling: PoorFree text: Persistent and suddden and dramatic increase of sorness in the shoulder four weeks after getting my second vaccination. Recurring cold in the eye and headache. Soreness in arm suddenly disappeared all together then minor soreness reoccurrence.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Survey response — day 35, dose 2MedDRA: Abnormal sensation in eye, Headache, Injection site pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Severe cold-in-the-eye and left hemispherical headaches corresponding to intramuscular pain from vaccination site. Symptoms intensified and faded correspondingly and have persisted for 11 days. Symptoms have abated somewhat the past couple days.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-07
- 2021-09-07
-
2021-11-18
Dose 3 — Pfizer-BioNTech
- 2022-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-08 | Pfizer-BioNTech | |
| 2 | 2021-03-08 | Pfizer-BioNTech | |
| 3 | 2021-11-18 | Pfizer-BioNTech | No |
Free text
Release 6 — day 28, dose 2
Symptoms: Persistent and suddden and dramatic increase of sorness in the shoulder four weeks after getting my second vaccination. Recurring cold in the eye and headache. Soreness in arm suddenly disappeared all together then minor soreness reoccurrence.
Release 7 — day 35, dose 2
Symptoms: Severe cold-in-the-eye and left hemispherical headaches corresponding to intramuscular pain from vaccination site. Symptoms intensified and faded correspondingly and have persisted for 11 days. Symptoms have abated somewhat the past couple days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abnormal sensation in eye | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Eye disorder | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release